Other acute postprocedural pain. Other acute postprocedural pain
Conditions
Interventions
Intervention 1: Control group: Patients received 17 ml of 0.25% bupivacaine + 3 ml of 0.9% saline in a total volume of 20 ml on each side. Intervention 2: Intervention group: Patients received 17 ml o
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ASA class I and II physical condition Age between 18-65 years
Exclusion criteria
Exclusion criteria: Patient refusal to participate Neuromuscular diseases (eg myopathy, myasthenia gravis) Hematological diseases, bleeding or coagulation disorders Local skin infection and sepsis at the block site Known hypersensitivity to study drugs Morbid obesity (BMI > -35.7 History of alcoholism or drug addiction Any uncompensated systemic disease (cardiovascular, respiratory, metabolic, neurological and endocrine) Other mental or emotional problems that may invalidate informed consent. Patients will be screened by a preoperative care nurse. Potentially eligible individuals will be directed to investigators for screening and additional information. Sleep apnea or any other sleep disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of patients' pain. Timepoint: zero, 2, 4, 6, 12 and 24 hours after the operation. Method of measurement: Visual Analogue Scale.;Sedation score. Timepoint: zero hours 2, 4, 6, 12 and 24 after the operation. Method of measurement: Reverse Observer Assessment Scale of Consciousness/Sedation (OAA/S). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlieh Zamani Kiasari
Mazandaran University of Medical Sciences
Outcome results
None listed